Jacobi Medical Center is a municipal hospital operated by NYC Health + Hospitals in affiliation with the Albert Einstein College of Medicine. The facility is located in the Morris Park neighborhood of the Bronx, New York City.

During the past decade, Jacobi Medical Center conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 52 clinical trials were completed, i.e. on average, 73.2% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 33 clinical trials were completed. i.e. 86.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jacobi Medical Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 65 trials, followed by "Gilead Sciences" with 14 trials sponsored, "Albert Einstein College of Medicine" with 10 trials sponsored, "New York City Health and Hospitals Corporation" with 10 trials sponsored and "International Maternal Pediatric Adolescent AIDS Clinical Trials Group" with 10 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 69 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jacobi Medical Center" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 34 trials as a collaborator, "Jacobi Medical Center" with 16 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 12 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 8 trials as a collaborator. Other collaborators include 130 different institutions and companies that were collaborators in the rest 95 trials.

According to Clinical.Site data, the most researched conditions in "Jacobi Medical Center" are "HIV Infections" (78 trials), "HIV" (12 trials), "COVID-19" (8 trials), "Sickle Cell Disease" (8 trials) and "HIV-1 Infection" (7 trials). Many other conditions were trialed in "Jacobi Medical Center" in a lesser frequency.

Most popular intervention types in "Jacobi Medical Center" are "Drug" (122 trials), "Behavioral" (19 trials), "Biological" (19 trials), "Other" (16 trials) and "Device" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Zidovudine" (12 trials), "Nevirapine" (8 trials), "Didanosine" (7 trials) and "Ritonavir" (7 trials). Other intervention names were less common.

The vast majority of trials in "Jacobi Medical Center" are 178 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Jacobi Medical Center". undefined are not yet recruiting, 21 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 142 completed trials in Jacobi Medical Center, 3 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Jacobi Medical Center, 26 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 38 trials that are defined as “Not Applicable".